Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Conference bursaries make malaria mission possible

July 8, 2010 10:39 am | by EurekAlert | News | Comments

(BioMed Central) Today, BioMed Central announced a fund to help researchers in developing countries attend the conference, Parasite to Prevention. The conference, held in conjunction with Malaria Journal, takes place in Edinburgh UK, Oct. 20-22, 2010.

TOPICS:

University of Manchester academics at international conference on geographic chemicals

July 8, 2010 10:39 am | by EurekAlert | News | Comments

(University of Manchester) A major conference, organized by scientists at the University of Manchester to showcase vital work on the effect of geographic chemicals, begins today.

TOPICS:

Nanotechnology: nanomaterials are widely used in commerce, but EPA faces challenges in regulating risk

July 8, 2010 10:39 am | by I-Micronews | News | Comments

Nanotechnology involves the ability to control matter at the scale of a nanometer--one billionth of a meter. The world market for products that contain nanomaterials is expected to reach $2.6 trillion by 2015.

Advertisement

The thinnest, smoothest metallic lines in the world helps speed up miniaturisation of electronic devices

July 8, 2010 10:39 am | by I-Micronews | News | Comments

New method creates super-thin, high integrity, continuous metal lines that surpass today?s semiconductor industry requirements.

Nichia to start sample shipment of green diode laser

July 8, 2010 10:39 am | by I-Micronews | News | Comments

Nichia Corp will finally commercialize its green diode laser for use mainly in pico projectors.

Genzyme to transfer more manufacturing to Hospira

July 8, 2010 10:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Genzyme Corp. is expanding a deal designed to transfer more so-called fill-finish manufacturing work to Hospira Worldwide Inc. – part of an agreement with the U.S. FDA to comply with an enforcement action against the Cambridge-based biotechnology company.

PEAK Surgical Introduces PEAK PlasmaBlade(R) 3.0S

July 8, 2010 10:37 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif. , July 8 /- PEAK Surgical, Inc. today announced the launch of the PEAK PlasmaBlade® 3.0S dissection device following 510(k) clearance from the U.S. Food and Drug Administration (FDA). This revolutionary product features a 3.0mm wide blade for even greater cutting...

TOPICS:

Unprecedented Donation Made by Mrs. Lily Safra to the Institute for Brain and Spinal Cord Disorders in Paris

July 8, 2010 10:37 am | by Bio-Medicine.Org | News | Comments

PARIS , July 8, 2010 /- Professor Gerard Saillant , President of the Institute for Brain and Spinal Cord Disorders (ICM), announced today an unprecedented donation of EUR8,000,000 from Mrs. Lily Safra . It is the largest single donation made by a private individual to the ICM. Professor Saillant...

TOPICS:
Advertisement

ECRI Institute Adds 4,000 New Terms to Universal Medical Device Nomenclature Systemâ„¢

July 8, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

Free license gives access to 24,544 terms, including genetic testing and device software PLYMOUTH MEETING, Pa. , July 8 /PRNewswire-USNewswire/ -- ECRI Institute's Universal Medical Device Nomenclature System™,  the most comprehensive medical device taxonomy, announces the...

TOPICS:

Exagen Diagnostics Receives Lab Accreditation From College of American Pathologists

July 8, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

ALBUQUERQUE, N.M. , July 8 /- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP). The CAP is a leading...

TOPICS:

Qualaquin (quinine sulfate): New Risk Evaluation and Mitigation Strategy - Risk of serious hematological reactions

July 8, 2010 10:31 am | by U.S. Food & Drug Administration | News | Comments

New Risk Management Plan. Reports of serious side effects in patients using Qualaquin "off-label" for night time leg cramps.

TOPICS:

MDT Forum

July 8, 2010 7:38 am | News | Comments

The MDT community forum is a great location to discuss new trends, share tips, give opinions, and exchange ideas.

PMA Final Decisions for May 2010

July 8, 2010 7:37 am | by U.S. Food & Drug Administration | News | Comments

These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for January 2010

TOPICS:

Federal Register: Guidance for Humanitarian Device Exemption Holders, Institutional Review Boards, Clinical Investigators, and Food and Drug Administration Staff; Humanitarian...

July 8, 2010 7:31 am | by U.S. Food & Drug Administration | News | Comments

This guidance answers commonly asked questions about Humanitarian Use Devices (HUDs) and applications for HDEs.

TOPICS:

Servo Drive Features Compact Space-Saving Design

July 8, 2010 6:46 am | Bosch Rexroth Corporation | Product Releases | Comments

The Rexroth IndraDrive Cs Economy low-power servo drive features an extremely compact space-saving design, and open support of SERCOS III communication bus, providing a cost-effective drive platform delivering just the right amount of functionality.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading